BRPI1008778A2 - método de amplificação de modelos de dna ricos em gc - Google Patents

método de amplificação de modelos de dna ricos em gc

Info

Publication number
BRPI1008778A2
BRPI1008778A2 BRPI1008778A BRPI1008778A BRPI1008778A2 BR PI1008778 A2 BRPI1008778 A2 BR PI1008778A2 BR PI1008778 A BRPI1008778 A BR PI1008778A BR PI1008778 A BRPI1008778 A BR PI1008778A BR PI1008778 A2 BRPI1008778 A2 BR PI1008778A2
Authority
BR
Brazil
Prior art keywords
amplification method
rich dna
dna models
models
rich
Prior art date
Application number
BRPI1008778A
Other languages
English (en)
Inventor
Gary J Latham
Original Assignee
Asuragen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42101877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI1008778(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Asuragen Inc filed Critical Asuragen Inc
Publication of BRPI1008778A2 publication Critical patent/BRPI1008778A2/pt
Publication of BRPI1008778B1 publication Critical patent/BRPI1008778B1/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811Selection methods for production or design of target specific oligonucleotides or binding molecules
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2521/00Reaction characterised by the enzymatic activity
    • C12Q2521/10Nucleotidyl transfering
    • C12Q2521/101DNA polymerase
BRPI1008778-8A 2009-02-13 2010-02-04 Método para aumentar a processabilidade de uma ou mais dna polimerases em pelo menos um modelo de dna rico em gc BRPI1008778B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/371,306 US8409805B2 (en) 2009-02-13 2009-02-13 Method of amplification of GC-rich DNA templates
US12/371,306 2009-02-13
PCT/US2010/023173 WO2010093552A1 (en) 2009-02-13 2010-02-04 Method of amplification of gc-rich dna templates

Publications (2)

Publication Number Publication Date
BRPI1008778A2 true BRPI1008778A2 (pt) 2016-09-06
BRPI1008778B1 BRPI1008778B1 (pt) 2021-03-23

Family

ID=42101877

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1008778-8A BRPI1008778B1 (pt) 2009-02-13 2010-02-04 Método para aumentar a processabilidade de uma ou mais dna polimerases em pelo menos um modelo de dna rico em gc

Country Status (10)

Country Link
US (1) US8409805B2 (pt)
EP (1) EP2396426B1 (pt)
KR (1) KR101784527B1 (pt)
CN (1) CN102395686B (pt)
AU (1) AU2010213981C1 (pt)
BR (1) BRPI1008778B1 (pt)
IL (1) IL214326A (pt)
RU (1) RU2011137526A (pt)
WO (1) WO2010093552A1 (pt)
ZA (1) ZA201105632B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102449171B (zh) * 2009-03-24 2015-12-02 奥斯瑞根公司 对fmr1和fmr2基因5’非翻译区进行表征的pcr方法
WO2011106368A2 (en) 2010-02-23 2011-09-01 Illumina, Inc. Amplification methods to minimise sequence specific bias
EP2633073B1 (en) * 2010-10-29 2017-04-26 Asuragen, Inc. mPCR METHODS FOR ANALYZING REPEAT SEQUENCES
ES2759023T3 (es) 2012-07-20 2020-05-07 Asuragen Inc Genotipificación completa de FMR1
CN103074329B (zh) * 2013-02-04 2014-05-14 首都师范大学 一种聚合酶链反应增强方法
WO2015073650A2 (en) 2013-11-13 2015-05-21 Counsyl, Inc. Automated nucleic acid repeat count calling methods
CN103981172A (zh) * 2014-03-27 2014-08-13 江苏佰龄全基因生物医学技术有限公司 一种用于高gc含量基因的pcr扩增添加剂组合物及高gc含量基因的pcr扩增方法
EP3371330A4 (en) 2015-11-03 2019-06-26 Asuragen, Inc. METHODS OF DETECTING THE DIMENSION OF A NUCLEIC ACID OF REPETITION SEQUENCES
CN106755414B (zh) * 2016-12-23 2020-09-01 宁波海尔施基因科技有限公司 一种检测dna遗传标记的方法
RU2620944C1 (ru) * 2016-12-27 2017-05-30 Федеральное государственное бюджетное научное учреждение "Научный центр неврологии" (ФГБНУ НЦН) Способ выявления экспансии тринуклеотидных CGG-повторов в 5'-нетранслируемой, промоторной области гена FMR1 при заболевании синдрома атаксии/тремора, ассоциированного с ломкой Х-хромосомы (FXTAS)
US11236384B2 (en) * 2017-01-19 2022-02-01 Asuragen, Inc. Methods of RNA amplification
CN106978484A (zh) * 2017-03-16 2017-07-25 北京博奥晶典生物技术有限公司 通过pcr添加剂解决等位基因扩增不平衡的方法
CO2017004500A1 (es) * 2017-05-03 2018-11-13 Univ Industrial De Santander Mezclas de nucleótidos para la amplificación y secuenciación de polimeros de ácidos nucleícos
CN107058576B (zh) * 2017-05-27 2021-01-05 上海百傲科技股份有限公司 基因芯片杂交组件、包含该杂交组件的试剂盒、其应用及杂交检测方法
CN108998465A (zh) * 2018-06-25 2018-12-14 浙江皇冠科技有限公司 重组微生物源天然虾青素基因工程菌及其产物的制备方法
CN109778321B (zh) * 2019-02-28 2020-06-30 北京先声医学检验实验室有限公司 一种用于宏基因组测序的建库方法、试剂盒和测序方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
WO1992014840A1 (fr) 1991-02-13 1992-09-03 Institut National De La Sante Et De La Recherche Medicale Fragment d'acide nucleique de la region du chromosome x implique dans le syndrome x fragile, sonde nucleotidique et procede pour le diagnostic du retard mental avec x fragile
US6200747B1 (en) 1992-01-28 2001-03-13 North Shore University Hospital Research Corp. Method and kits for detection of fragile X specific, GC-rich DNA sequences
US5648211A (en) 1994-04-18 1997-07-15 Becton, Dickinson And Company Strand displacement amplification using thermophilic enzymes
EP0714980A1 (en) 1994-12-02 1996-06-05 Institut Pasteur Hypermutagenesis
US5976842A (en) * 1997-10-30 1999-11-02 Clontech Laboratories, Inc. Methods and compositions for use in high fidelity polymerase chain reaction
US6787305B1 (en) * 1998-03-13 2004-09-07 Invitrogen Corporation Compositions and methods for enhanced synthesis of nucleic acid molecules
US6287824B1 (en) 1998-09-15 2001-09-11 Yale University Molecular cloning using rolling circle amplification
US6143504A (en) * 1998-10-27 2000-11-07 Arch Development Corporation Methods and compositions for the diagnosis of fragile X syndrome
DE1020534T1 (de) 1998-11-09 2001-03-01 Eiken Chemical Verfahren zur synthetisieren von nukleinsäure
US6335165B1 (en) 1999-01-25 2002-01-01 Gamidagen Ltd. Methods and kits for characterizing GC-rich nucleic acid sequences
US6326173B1 (en) 1999-04-12 2001-12-04 Nanogen/Becton Dickinson Partnership Electronically mediated nucleic acid amplification in NASBA
EP1088891B1 (en) 1999-09-28 2005-01-12 Roche Diagnostics GmbH Thermostable enzyme promoting the fidelity of thermostable DNA polymerases - for improvement of nucleic acid synthesis and amplification in vitro
US6670124B1 (en) * 1999-12-20 2003-12-30 Stemcyte, Inc. High throughput methods of HLA typing
JP2001269188A (ja) 2000-03-11 2001-10-02 Roche Diagnostics Gmbh Pcrにおける性能が向上したb型dnaポリメラーゼ変異体
US20070207463A1 (en) * 2003-11-20 2007-09-06 Ziduo Liu Method
EP1910528A2 (de) 2005-07-25 2008-04-16 Technische Universität Dresden Rna-abhängige rna-polymerase, verfahren und kits zur amplifikation und / oder markierung von rna
US7855053B2 (en) 2006-07-19 2010-12-21 The Regents Of The University Of California Methods for detecting the presence of expanded CGG repeats in the FMR1 gene 5′ untranslated region
US8163480B2 (en) * 2006-10-05 2012-04-24 Quest Diagnostics Investments Incorporated Nucleic acid size detection method

Also Published As

Publication number Publication date
CN102395686A (zh) 2012-03-28
CN102395686B (zh) 2015-05-13
EP2396426A1 (en) 2011-12-21
US20100209970A1 (en) 2010-08-19
BRPI1008778B1 (pt) 2021-03-23
EP2396426B1 (en) 2014-11-26
ZA201105632B (en) 2012-04-25
IL214326A0 (en) 2011-09-27
IL214326A (en) 2015-03-31
WO2010093552A1 (en) 2010-08-19
US8409805B2 (en) 2013-04-02
AU2010213981A1 (en) 2011-08-18
AU2010213981C1 (en) 2014-06-26
AU2010213981B2 (en) 2013-11-28
KR101784527B1 (ko) 2017-10-11
KR20110120923A (ko) 2011-11-04
RU2011137526A (ru) 2013-03-20

Similar Documents

Publication Publication Date Title
BRPI1008778A2 (pt) método de amplificação de modelos de dna ricos em gc
BR112012004707A2 (pt) método
BR112012000624A2 (pt) método
FI20090389A0 (fi) Menetelmä
BRPI0919116A2 (pt) método
BRPI1013317A2 (pt) método de cimentação
BRPI0907376A8 (pt) fotobiorreator
DK2072600T3 (da) Fremgangsmåde til at forbedre jord
BRPI1012526A2 (pt) método
BR112012005146A2 (pt) fotobiorreator
DK2313489T3 (da) Fremstillingsmetode
BRPI0920540A2 (pt) método de produção de álcool
BRPI1010705A2 (pt) método
HK1162196A1 (en) Method for quantification of small rna species rna
DK2408807T3 (da) Fremgangsmåde til terapeutisk anvendelse
BR112012003084A2 (pt) metodo de determinação de mudança de endrenagem
BRPI1012532A2 (pt) método
BRPI0722315A2 (pt) Método de cultura microbiana em larga escala
BRPI0920620A2 (pt) fabricação de cetonas gama-delta insaturadas
DK2262739T3 (da) Fremgangsmåde til neutralisering af mikroorganismer
BRPI1009018A2 (pt) fotobiorreator
DK2326332T3 (da) Fremgangsmåde til behandling af sygdomme
BRPI0916597A2 (pt) Método
BRPI1009350A2 (pt) método
IS8917A (is) Aðferð til að smíða skó

Legal Events

Date Code Title Description
B11Z Dismissal: petition dismissal - article 216, par 2 of industrial property law

Free format text: ARQUIVAMENTO POR NAO APRESENTAR A PROCURACAO NO PRAZO DE 60 (SESSENTA) DIAS A CONTAR DA DATA DE APRESENTACAO DA PETICAO DE ENTRADA NA FASE NACIONAL, CONFORME ESTABELECE ART. 216 2O DA LPI (LEI NO 9.279/1996).

B11M Decision cancelled [chapter 11.13 patent gazette]

Free format text: ANULADO O DESPACHO 11.6.1 POR TER SIDO INDEVIDA

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 23/03/2021, OBSERVADAS AS CONDICOES LEGAIS.